| abstract |
The present invention is a method of producing porous silica particles comprising at least one bioactive compound, said particles being suitable for the delivery of said at least one bioactive compound to the lung, nose, sublingual and/or pharynx. And having a MMAD of 0.5 to 15 μm with a GSD of less than 2.5. The invention also relates to a pharmaceutical composition comprising said silica particles and the use of said silica particles in the diagnosis, prophylaxis and/or treatment of local and/or systemic diseases such as lung, nose, sublingual and/or pharyngeal diseases. Concerned. [Selection diagram] None |